Myocardial Perfusion Imaging Using Contrast Echocardiography

Progress in Cardiovascular Diseases

Volumn 57, Issue 6, 2015, Pages 632-643

  Pathan, Faraz ^a   Marwick, Thomas H ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Contrast echocardiography; Coronary artery disease; Diagnosis; Myocardial perfusion; Prognosis

Indexed keywords

CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIAC IMAGING; CLINICAL EVALUATION; CONTRAST ECHOCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; MYOCARDIAL PERFUSION IMAGING; PHYSIOLOGICAL STRESS; PROGNOSIS; PROGNOSTIC ASSESSMENT; RADIATION SAFETY; ANIMAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC USE; ECHOCARDIOGRAPHY; ECHOGRAPHY; MICROBUBBLE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES;

ANIMALS; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY; HUMANS; MICROBUBBLES; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84930046562     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.03.005     Document Type: Article

References (62)

1. Keller M.W., Segal S.S., Kaul S., Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989, 65:458-467.
2. Moir S., Marwick T.H. Combination of contrast with stress echocardiography: a practical guide to methods and interpretation. Cardiovasc Ultrasound 2004, 2:15.
3. Lindner J.R., Wei K. Contrast echocardiography. Curr Probl Cardiol 2002, 27:454-519.
4. Tsutsui J.M., Xie F., McGrain A.C., et al. Comparison of low-mechanical index pulse sequence schemes for detecting myocardial perfusion abnormalities during vasodilator stress echocardiography. Am J Cardiol 2005, 95:565-570.
5. Jayaweera A.R., Edwards N., Glasheen W.P., Villanueva F.S., Abbott R.D., Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res 1994, 74:1157-1165.
6. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483.
7. Vogel R., Indermühle A., Reinhardt J., et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography algorithm and validation. J Am Coll Cardiol 2005, 45:754-762.
8. Jayaweera A.R., Wei K., Coggins M., Bin J.P., Goodman C., Kaul S. Role of capillaries in determining cbf reserve: new insights using myocardial contrast echocardiography. Am J Physiol 1999, 277:H2363-H2372.
9. Porter T.R., Xie F. Myocardial perfusion imaging with contrast ultrasound. JACC Cardiovasc Imaging 2010, 3:176-187.
10. Wei K., Ragosta M., Thorpe J., Coggins M., Moos S., Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 2001, 103:2560-2565.
11. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion?. J Am Coll Cardiol 1998, 32:252-260.
12. Kaul S. Myocardial contrast echocardiography: a 25-year retrospective. Circulation 2008, 118:291-308.
13. Senior R., Janardhanan R., Jeetley P., Burden L. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation 2005, 112:1587-1593.
14. Monaghan M.J. Stress myocardial contrast echocardiography. Heart 2003, 89:1391-1393.
15. Witt S.A., McCulloch M., Sisk E., et al. Achieving a diagnostic contrast-enhanced echocardiogram: a series on contrast echocardiography, article 4. J Am Soc Echocardiogr 2001, 14:327-334.
16. Gaibazzi N., Rigo F., Reverberi C. Detection of coronary artery disease by combined assessment of wall motion, myocardial perfusion and coronary flow reserve: a multiparametric contrast stress-echocardiography study. J Am Soc Echocardiogr 2010, 23:1242-1250.
17. Bhatia V.K., Senior R. Contrast echocardiography: evidence for clinical use. J Am Soc Echocardiogr 2008, 21:409-416.
18. Dijkmans P.A., Senior R., Becher H., et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion the evidence so far. J Am Coll Cardiol 2006, 48:2168-2177.
19. Arnold J.R., Karamitsos T.D., Pegg T.J., et al. Adenosine stress myocardial contrast echocardiography for the detection of coronary artery diseases comparison with coronary angiography and cardiac magnetic resonance. J Am Coll Cardiol Img 2010, 3:934-943.
20. Senior R., Monaghan M., Main M.L., et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two phase 3 international trials in comparison with radionuclide perfusion imaging. Eur J Echocardiogr 2009, 10:26-35.
21. Senior R., Moreo A., Gaibazzi N., et al. Comparison of sulfur hexafluoride microbubble (sonovue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large european multicenter study. J Am Coll Cardiol 2013, 62:1353-1361.
22. Gaibazzi N., Squeri A., Reverberi C., et al. Contrast stress-echocardiography predicts cardiac events in patients with suspected acute coronary syndrome but nondiagnostic electrocardiogram and normal 12-hour troponin. J Am Soc Echocardiogr 2011, 24:1333-1341.
23. Kang D.H., Kang S.J., Song J.M., et al. Efficacy of myocardial contrast echocardiography in the diagnosis and risk stratification of acute coronary syndrome. Am J Cardiol 2005, 96:1498-1502.
24. Kemper A.J., O'Boyle J.E., Cohen C.A., Taylor A., Parisi A.F. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation 1984, 70:309-317.
25. Ragosta M., Camarano G., Kaul S., Powers E.R., Sarembock I.J., Gimple L.W. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994, 89:2562-2569.
26. Janardhanan R., Moon J.C., Pennell D.J., Senior R. Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction. Am Heart J 2005, 149:355-362.
27. Senior R., Becher H., Monaghan M., et al. Contrast echocardiography: evidence-based recommendations by european association of echocardiography. Eur J Echocardiogr 2009, 10:194-212.
28. Shimoni S., Frangogiannis N.G., Aggeli C.J., et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003, 107:538-544.
29. Sicari R., Pasanisi E., Venneri L., Landi P., Cortigiani L., Picano E. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003, 41:589-595.
30. Tsutsui J.M., Elhendy A., Anderson J.R., Xie F., McGrain A.C., Porter T.R. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005, 112:1444-1450.
31. Tsutsui J.M., Xie F., Cloutier D., Kalvaitis S., Elhendy A., Porter T.R. Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J 2008, 29:377-385.
32. Dawson D., Kaul S., Peters D., et al. Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography. J Am Soc Echocardiogr 2009, 22:954-960.
33. Wejner-Mik P., Lipiec P., Kasprzak J.D. Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography. Eur J Echocardiogr 2011, 12:762-766.
34. Anantharam B., Janardhanan R., Hayat S., et al. Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure. Eur J Echocardiogr 2011, 12:69-75.
35. Wei K., Mulvagh S.L., Carson L., et al. The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 2008, 21:1202-1206.
36. Platts D.G., Luis S.A., Roper D., et al. The safety profile of perflutren microsphere contrast echocardiography during rest and stress imaging: results from an australian multicentre cohort. Heart Lung Circ 2013, 22:996-1002.
37. Weiss R.J., Ahmad M., Villanueva F., et al. Cares (contrast echocardiography registry for safety surveillance): a prospective multicenter study to evaluate the safety of the ultrasound contrast agent definity in clinical practice. J Am Soc Echocardiogr 2012, 25:790-795.
38. United States Food and Drug Administration accessed 3/21/2015. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm125574.htm.
39. Main M.L., Ryan A.C., Davis T.E., Albano M.P., Kusnetzky L.L., Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008, 102:1742-1746.
40. Abdelmoneim S.S., Bernier M., Scott C.G., et al. Safety of contrast agent use during stress echocardiography a 4-year experience from a single-center cohort study of 26,774 patients. J Am Coll Cardiol Img 2009, 2:1048-1056.
41. Main M.L., Hibberd M.G., Ryan A., Lowe T.J., Miller P., Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. J Am Coll Cardiol Img 2014, 7:40-48.
42. Nucifora G., Marsan N.A., Siebelink H.M., et al. Safety of contrast-enhanced echocardiography within 24h after acute myocardial infarction. Eur J Echocardiogr 2008, 9:816-818.
43. Wei K., Main M.L., Lang R.M., et al. The effect of definity on systemic and pulmonary hemodynamics in patients. J Am Soc Echocardiogr 2012, 25:584-588.
44. Abdelmoneim S.S., Bernier M., Scott C.G., et al. Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study. Circ Cardiovasc Imaging 2010, 3:240-248.
45. Wever-Pinzon O., Suma V., Ahuja A., et al. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. Eur Heart J Cardiovasc Imaging 2012, 13:857-862.
46. Lindner J.R., Song J., Jayaweera A.R., Sklenar J., Kaul S. Microvascular rheology of definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 2002, 15:396-403.
47. Parker J.M., Weller M.W., Feinstein L.M., et al. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol 2013, 112:1039-1045.
48. Davidson B.P., Kaufmann B.A., Belcik J.T., Xie A., Qi Y., Lindner J.R. Detection of antecedent myocardial ischemia with multiselectin molecular imaging. J Am Coll Cardiol 2012, 60:1690-1697.
49. Kee P.H., Kim H., Huang S., et al. Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes. Ultrasound Med Biol 2014, 40:1167-1176.
50. Kaufmann B.A., Sanders J.M., Davis C., et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007, 116:276-284.
51. Schumann P.A., Christiansen J.P., Quigley R.M., et al. Targeted-microbubble binding selectively to gpiib iiia receptors of platelet thrombi. Investig Radiol 2002, 37:587-593.
52. Lanza G.M., Wallace K.D., Scott M.J., et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94:3334-3340.
53. Leong-Poi H., Christiansen J., Klibanov A.L., Kaul S., Lindner J.R. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 2003, 107:455-460.
54. Dijkmans P.A., Juffermans L.J.M., Musters R.J.P., et al. Microbubbles and ultrasound: from diagnosis to therapy. Eur Heart J Cardiovasc Imaging 2004, 5:245-256.
55. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003, 108:1022-1026.
56. Alexandrov A.V., Molina C.A., Grotta J.C., et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170-2178.
57. Tsivgoulis G., Eggers J., Ribo M., et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010, 41:280-287.
58. Hudson M., Greenbaum A., Brenton L., et al. Adjunctive transcutaneous ultrasound with thrombolysis: results of the plus (perfusion by thrombolytic and ultrasound) trial. J Am Coll Cardiol Intv 2010, 3:352-359.
59. Xie F., Lof J., Matsunaga T., Zutshi R., Porter T.R. Diagnostic ultrasound combined with glycoprotein iib/iiia-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions. Circulation 2009, 119:1378-1385.
60. Tonino P.A.L., De Bruyne B., Pijls N.H.J., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009, 360:213-224.
61. De Bruyne B., Pijls N.H.J., Kalesan B., et al. Fractional flow reserve-guided pci versus medical therapy in stable coronary disease. N Engl J Med 2012, 367:991-1001.
62. Thomas J.D. Myocardial contrast echocardiography perfusion imaging: still waiting after all these years. J Am Coll Cardiol 2013, 62:1362-1364.